← Leaderboards
Marya Lieberman
University Of Notre Dame
$2,020,281
Attributed
$2,020,281
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $604.9K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,020,281 · 1
By mechanism
U01$2,020,281 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Notre Dame
Same institution · by research overlap
- Nora J Besansky$11,777,101
- Michael T Ferdig$11,375,095
- Marya Lieberman$2,229,201
- Amitabh Chaudhary$175,862
- Peter Kilpatrick$141,193
Others in their field
Other Rising Stars on “Malignant Neoplasms”
- David Annett · Information Management Services, Inc.$35,571,865
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Jon White · Midwest Research Institute$17,594,074
- Carolina Porras · Fundacion Inciensa$10,814,023
- Alanna Maguire · Mayo Clinic Rochester$9,942,431
- Hill Georgette · Integrated Laboratory Systems, Llc$8,700,000
Research focus
Malignant NeoplasmsDrug QualityScreeningPharmacologic SubstanceAfrica South Of The SaharaHospitalsLow And Middle-Income CountriesResearch PersonnelChemotherapyTechnologyCameroonClinicClinics And HospitalsCold ChainsInjectableLeftEthicsAwarenessCountryEthiopiaHigh Pressure Liquid ChromatographyDevelopment PlansDropsCost-Effectiveness Evaluation
Grant awards (5)
Adapting a point of use test card, the chemoPAD, for protecting chemotherapy drug quality in sub-Saharan Africa$468,026
U01 · FY2025 · CA · contact PI
Adapting a point of use test card, the chemoPAD, for protecting chemotherapy drug quality in sub-Saharan Africa$448,376
U01 · FY2024 · CA · contact PI
Point of use detection of low-quality pharmaceutical asparaginase$156,500
U01 · FY2024 · CA · contact PI
Adapting a point of use test card, the chemoPAD, for protecting chemotherapy drug quality in sub-Saharan Africa$461,516
U01 · FY2023 · CA · contact PI
Adapting a point of use test card, the chemoPAD, for protecting chemotherapy drug quality in sub-Saharan Africa$485,863
U01 · FY2022 · CA · contact PI